Aeroplysinin-1, a Sponge-Derived Multi-Targeted Bioactive Marine Drug

Organisms lacking external defense mechanisms have developed chemical defense strategies, particularly through the production of secondary metabolites with antibiotic or repellent effects. Secondary metabolites from marine organisms have proven to be an exceptionally rich source of small molecules w...

Full description

Bibliographic Details
Main Authors: Javier A. García-Vilas, Beatriz Martínez-Poveda, Ana R. Quesada, Miguel Ángel Medina
Format: Article
Language:English
Published: MDPI AG 2015-12-01
Series:Marine Drugs
Subjects:
Online Access:http://www.mdpi.com/1660-3397/14/1/1
_version_ 1798003541557641216
author Javier A. García-Vilas
Beatriz Martínez-Poveda
Ana R. Quesada
Miguel Ángel Medina
author_facet Javier A. García-Vilas
Beatriz Martínez-Poveda
Ana R. Quesada
Miguel Ángel Medina
author_sort Javier A. García-Vilas
collection DOAJ
description Organisms lacking external defense mechanisms have developed chemical defense strategies, particularly through the production of secondary metabolites with antibiotic or repellent effects. Secondary metabolites from marine organisms have proven to be an exceptionally rich source of small molecules with pharmacological activities potentially beneficial to human health. (+)-Aeroplysinin-1 is a secondary metabolite isolated from marine sponges with a wide spectrum of bio-activities. (+)-Aeroplysinin-1 has potent antibiotic effects on Gram-positive bacteria and several dinoflagellate microalgae causing toxic blooms. In preclinical studies, (+)-aeroplysinin-1 has been shown to have promising anti-inflammatory, anti-angiogenic and anti-tumor effects. Due to its versatility, (+)-aeroplysinin-1 might have a pharmaceutical interest for the treatment of different pathologies.
first_indexed 2024-04-11T12:10:33Z
format Article
id doaj.art-325fcdb0fb734a8ea787d70306746a6c
institution Directory Open Access Journal
issn 1660-3397
language English
last_indexed 2024-04-11T12:10:33Z
publishDate 2015-12-01
publisher MDPI AG
record_format Article
series Marine Drugs
spelling doaj.art-325fcdb0fb734a8ea787d70306746a6c2022-12-22T04:24:38ZengMDPI AGMarine Drugs1660-33972015-12-01141110.3390/md14010001md14010001Aeroplysinin-1, a Sponge-Derived Multi-Targeted Bioactive Marine DrugJavier A. García-Vilas0Beatriz Martínez-Poveda1Ana R. Quesada2Miguel Ángel Medina3Departamento de Biología Molecular y Bioquímica, Facultad de Ciencias, and IBIMA (Biomedical Research Institute of Málaga), Universidad de Málaga, Andalucía Tech, Málaga 29071, SpainDepartamento de Biología Molecular y Bioquímica, Facultad de Ciencias, and IBIMA (Biomedical Research Institute of Málaga), Universidad de Málaga, Andalucía Tech, Málaga 29071, SpainDepartamento de Biología Molecular y Bioquímica, Facultad de Ciencias, and IBIMA (Biomedical Research Institute of Málaga), Universidad de Málaga, Andalucía Tech, Málaga 29071, SpainDepartamento de Biología Molecular y Bioquímica, Facultad de Ciencias, and IBIMA (Biomedical Research Institute of Málaga), Universidad de Málaga, Andalucía Tech, Málaga 29071, SpainOrganisms lacking external defense mechanisms have developed chemical defense strategies, particularly through the production of secondary metabolites with antibiotic or repellent effects. Secondary metabolites from marine organisms have proven to be an exceptionally rich source of small molecules with pharmacological activities potentially beneficial to human health. (+)-Aeroplysinin-1 is a secondary metabolite isolated from marine sponges with a wide spectrum of bio-activities. (+)-Aeroplysinin-1 has potent antibiotic effects on Gram-positive bacteria and several dinoflagellate microalgae causing toxic blooms. In preclinical studies, (+)-aeroplysinin-1 has been shown to have promising anti-inflammatory, anti-angiogenic and anti-tumor effects. Due to its versatility, (+)-aeroplysinin-1 might have a pharmaceutical interest for the treatment of different pathologies.http://www.mdpi.com/1660-3397/14/1/1(+)-aeroplysinin-1spongesmarine drugsinflammationangiogenesiscancer
spellingShingle Javier A. García-Vilas
Beatriz Martínez-Poveda
Ana R. Quesada
Miguel Ángel Medina
Aeroplysinin-1, a Sponge-Derived Multi-Targeted Bioactive Marine Drug
Marine Drugs
(+)-aeroplysinin-1
sponges
marine drugs
inflammation
angiogenesis
cancer
title Aeroplysinin-1, a Sponge-Derived Multi-Targeted Bioactive Marine Drug
title_full Aeroplysinin-1, a Sponge-Derived Multi-Targeted Bioactive Marine Drug
title_fullStr Aeroplysinin-1, a Sponge-Derived Multi-Targeted Bioactive Marine Drug
title_full_unstemmed Aeroplysinin-1, a Sponge-Derived Multi-Targeted Bioactive Marine Drug
title_short Aeroplysinin-1, a Sponge-Derived Multi-Targeted Bioactive Marine Drug
title_sort aeroplysinin 1 a sponge derived multi targeted bioactive marine drug
topic (+)-aeroplysinin-1
sponges
marine drugs
inflammation
angiogenesis
cancer
url http://www.mdpi.com/1660-3397/14/1/1
work_keys_str_mv AT javieragarciavilas aeroplysinin1aspongederivedmultitargetedbioactivemarinedrug
AT beatrizmartinezpoveda aeroplysinin1aspongederivedmultitargetedbioactivemarinedrug
AT anarquesada aeroplysinin1aspongederivedmultitargetedbioactivemarinedrug
AT miguelangelmedina aeroplysinin1aspongederivedmultitargetedbioactivemarinedrug